ETFDH

From Wikipedia, the free encyclopedia


Electron-transferring-flavoprotein dehydrogenase
PDB rendering based on 2gmh.
Available structures: 2gmh, 2gmj
Identifiers
Symbol(s) ETFDH; MADD; ETFQO
External IDs OMIM: 231675 MGI106100 HomoloGene3275
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 2110 66841
Ensembl ENSG00000171503 ENSMUSG00000027809
Uniprot Q16134 Q6PF96
Refseq NM_004453 (mRNA)
NP_004444 (protein)
NM_025794 (mRNA)
NP_080070 (protein)
Location Chr 4: 159.81 - 159.85 Mb Chr 3: 79.69 - 79.71 Mb
Pubmed search [1] [2]

Electron-transferring-flavoprotein dehydrogenase, also known as ETFDH, is a human gene.[1]

Electron-transferring-flavoprotein dehydrogenase in the inner mitochondrial membrane accepts electrons from electron-transfer flavoprotein which is located in the mitochondrial matrix and reduces ubiquinone in the mitochondrial membrane. The protein is synthesized as a 67-kDa precursor which is targeted to mitochondria and processed in a single step to a 64-kDa mature form located in the mitochondrial membrane. Deficiency in electron-transferring-flavoprotein dehydrogenase have been demonstrated in some patients with type II glutaricacidemia.[1]

[edit] References

[edit] Further reading

  • Olsen RK, Olpin SE, Andresen BS, et al. (2007). "ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency.". Brain 130 (Pt 8): 2045–54. doi:10.1093/brain/awm135. PMID 17584774. 
  • Gempel K, Topaloglu H, Talim B, et al. (2007). "The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene.". Brain 130 (Pt 8): 2037–44. doi:10.1093/brain/awm054. PMID 17412732. 
  • Kimura K, Wakamatsu A, Suzuki Y, et al. (2006). "Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.". Genome Res. 16 (1): 55–65. doi:10.1101/gr.4039406. PMID 16344560. 
  • Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334. 
  • Olsen RK, Andresen BS, Christensen E, et al. (2003). "Clear relationship between ETF/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation deficiency.". Hum. Mutat. 22 (1): 12–23. doi:10.1002/humu.10226. PMID 12815589. 
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932. 
  • Goodman SI, Binard RJ, Woontner MR, Frerman FE (2003). "Glutaric acidemia type II: gene structure and mutations of the electron transfer flavoprotein:ubiquinone oxidoreductase (ETF:QO) gene.". Mol. Genet. Metab. 77 (1-2): 86–90. PMID 12359134. 
  • Simkovic M, Degala GD, Eaton SS, Frerman FE (2002). "Expression of human electron transfer flavoprotein-ubiquinone oxidoreductase from a baculovirus vector: kinetic and spectral characterization of the human protein.". Biochem. J. 364 (Pt 3): 659–67. doi:10.1042/BJ20020042. PMID 12049629. 
  • White RA, Dowler LL, Angeloni SV, Koeller DM (1996). "Assignment of Etfdh, Etfb, and Etfa to chromosomes 3, 7, and 13: the mouse homologs of genes responsible for glutaric acidemia type II in human.". Genomics 33 (1): 131–4. doi:10.1006/geno.1996.0170. PMID 8617498. 
  • Goodman SI, Axtell KM, Bindoff LA, et al. (1994). "Molecular cloning and expression of a cDNA encoding human electron transfer flavoprotein-ubiquinone oxidoreductase.". Eur. J. Biochem. 219 (1-2): 277–86. PMID 8306995.